Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors
Top Cited Papers
- 6 July 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 50 (16), 3825-3840
- https://doi.org/10.1021/jm070270t
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolaseBioorganic & Medicinal Chemistry, 2007
- Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Peptidyl-urea based inhibitors of soluble epoxide hydrolasesBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolaseBioorganic & Medicinal Chemistry Letters, 2006
- Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitorsProceedings of the National Academy of Sciences of the United States of America, 2006
- High-throughput pharmacokinetic method: Cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysisAnalytica Chimica Acta, 2006
- Efficient Route to the Pineal Hormone Melatonin by Radical-Based Indole SynthesisSynthetic Communications, 2003
- The expression domain of PHANTASTICA determines leaflet placement in compound leavesNature, 2003
- Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteinsFEBS Letters, 1994
- Cytosolic epoxide hydrolaseChemico-Biological Interactions, 1988